from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0734/mapA

LFCtreatmentdescriptionclass of inhibitor

-1.915

Amikacinug/mL Amikacintranslation

-1.671

Cap5-10ug/mL Capreomycintranslation

-1.322

Rox10-50 ug/mL Roxithromycintranslation

-0.155

SM2-5 ug/mL Streptomycintranslation

-1.645

Tet5-10 ug/mL Tetracyclinetranslation

-0.046

Rif0.2-5ug/mL Rifampicintranscription

0.156

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.104

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.672

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.543

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.360

Clofazimine10-13 ug/mL Clofaziminerespiration

0.093

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.074

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.572

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.293

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.033

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.043

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.800

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.011

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.048

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.166

KCN5-20 ug/mL Potassium cyaniderespiration

0.288

NaN30.2-2 mM Sodium aziderespiration

-0.623

Nigericin50 uM Nigericinrespiration

-0.935

TRC10-150 ug/mL Triclosanrespiration

-1.853

TRZ10-25 ug/mL Thioridazinerespiration

-1.450

Valinomycin0.5-10 uM Valinomycinrespiration

0.050

ZnSO42 mM ZnSO4respiration

0.137

menadione6-10 ug/mL Menadionerespiration

0.239

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.728

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.276

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.313

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.556

NRP_1Non-replicating persistence stage 1dosRassociated

0.708

Amp0.2mg/mL AmpicillincellWall

0.626

Cephalexin20-100 ug/mL CephalexincellWall

0.063

Cerulenin0.32-5 ug/mL CerulenincellWall

0.932

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.407

EMB10-20 ug/mL EthambutolcellWall

-0.063

Eta12-40 ug/mL EthionamidecellWall

-0.127

INH0.2-0.4 ug/mL IsoniazidcellWall

0.084

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.390

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.002

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.444

BZA0.12 mg/mL BenzamidearomaticAmides

0.584

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.207

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.594

H2O24 mM hydrogen peroxideDNAdamaging

-0.055

Levo10 ug/mL LevofloxacinDNAdamaging

0.935

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.423

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.249

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.134

UVUV-irradiationDNAdamaging

-0.133

ARP41-4 ug/mL Antitubercular compound ARP4?

0.594

Antimycin12.5-50 ug/mL Antimycin A?

0.284

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.889

PA_110-50 ug/mL Antitubercular compound PA-1?

0.490

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.546

PA8240.2-2 ug/mL PA-824?

-0.317

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.375

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.156

Verapamil50 uM Verapamil?

0.395

mercaptoethanol2 mM 2-Mercaptoethanol?

0.476

methoxatin10-20 ug/mL Methoxatin?